Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. Net Income 2022–2025
Orchestra BioMed Holdings, Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Orchestra BioMed Holdings, Inc. net income for the quarter ending March 31, 2026 was -20.7 M, a 10.32% increase year-over-year.
- Orchestra BioMed Holdings, Inc. net income for the twelve months ending March 31, 2026 was -79.6 M, a 36.87% increase year-over-year.
- Orchestra BioMed Holdings, Inc. annual net income for 2025 was -52.7 M, a 13.64% decrease from 2024.
- Orchestra BioMed Holdings, Inc. annual net income for 2024 was -61.0 M, a 24.23% increase from 2023.
- Orchestra BioMed Holdings, Inc. annual net income for 2023 was -49.1 M, a 46.16% increase from 2022.
- Orchestra BioMed Holdings, Inc. annual net income for 2022 was -33.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Orchestra BioMed Holdings, Inc. Net Income — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Orchestra BioMed Holdings, Inc.'s net income?
Orchestra BioMed Holdings, Inc. (OBIO) reported net income of -$53M for fiscal 2025.
Where can I see OBIO's net income history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s net income by year and by quarter, including the growth rate.